RGK-11950-60709 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-07
Dose 1 — Janssen/Johnson & Johnson
2021-05-12
Registered in v-safe
2021-05-12
Survey response — day 35, single dose
MedDRA: Eye pain, Headache — Feeling: Fair

Free text: Terrible headaches and sharp pains behind My eyes. It comes and goes.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-21
Survey response — day 42, single dose
MedDRA: Headache — Feeling: Good

Free text: Severe headaches that were often, but have slowly lightened up.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-10-06
Survey response — 6 months, dose 1
MedDRA: Eye pain, Heavy menstrual bleeding, Menstruation irregular — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Stabbing eye pain behind one eye and heavier bleeding. Irregular periods and constant eye pain.

MedDRA releases: 2024-11 · check-in free text available
2021-10-06
Report sent to call center — 6 months, dose 1
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-11-10
Call 1 — Left Voicemail
2021-11-13
Call 2 — Requested Callback

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-07	Janssen/Johnson & Johnson

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 8 — day 35, single dose

2021-05-12

Symptoms: Terrible headaches and sharp pains behind My eyes. It comes and goes.

Release 8 — day 42, single dose

2021-05-21

Symptoms: Severe headaches that were often, but have slowly lightened up.

Release 10 — 6 months, dose 1

2021-10-06

Symptoms: Stabbing eye pain behind one eye and heavier bleeding. Irregular periods and constant eye pain.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Eye pain	✓	✓	✓
SD	Headache	✓	✓	✓
SD	Heavy menstrual bleeding	·	·	✓
SD	Menstruation irregular	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release